On February 24, 2017, Mr. Michael Bruch, Chief Financial Officer, and Cesca Therapeutics Inc. mutually agreed to terminate his employment effective March 10, 2017. Also, as a result of Mr. Bruch's termination of employment, Mr. Jeff Cauble has been appointed Principal Financial Officer and Principal Accounting Officer, effective March 10, 2017. Mr. Cauble has over 19 years of accounting experience in various financial and managerial roles for Diamond Foods Inc. (DMND) and E.&J. Gallo Winery.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 USD | -2.36% | -3.46% | +11.48% |
Apr. 16 | ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.48% | 5.33M | |
+10.45% | 8.23B | |
-3.84% | 4.66B | |
-7.28% | 2.9B | |
+5.67% | 2.14B | |
-25.01% | 1.15B | |
-7.09% | 815M | |
-22.40% | 764M | |
-23.70% | 681M | |
-58.00% | 666M |
- Stock Market
- Equities
- THMO Stock
- News ThermoGenesis Holdings, Inc.
- Cesca Therapeutics Inc. Announces Management Changes